New functions for the supply of aids and medicines in the ALS app

We are constantly developing the ALS app with innovative ideas and feedback from our users. The latest version of the ALS app with new functions is available for download free of charge from the

The ALS app supports the first genetic therapy for ALS with mutation in the SOD1 gene.

Since March 2022, two patients have been treated with the drug Tofersen at the ALS outpatient clinic of the Charité in Berlin. The documentation and monitoring of the course of treatment are

Start of the Id-ALS study: identification of genetic alterations in people with ALS

The Id-ALS study is a research program to identify genetic alterations in people with amyotrophic lateral sclerosis (ALS). The study is organized by APST. The Alfried Krupp Hospital in Essen and

NF-L analysis results can now be viewed on the ALS app and in the APST web portal

More than 1,100 people with amyotrophic lateral sclerosis (ALS) are currently participating in the study “NF-L in ALS”, which is made possible by the Boris Canessa ALS Foundation

Care algorithm – improving the provision of care in cases of ALS

An algorithm, according to Wikipedia, is a “unique set of instructions for solving a problem”. In a digital care algorithm, a course of action for solving a care problem is